EBITDA: Income before interest, taxes, depreciation and amortization.
Arcadia Biosciences, Inc. (RKDA) had EBITDA of $-0.47M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.46M |
|
$-4.46M |
|
$0.82M |
|
$0.63M |
|
$1.96M |
|
$-0.50M |
|
$-3.96M |
|
$-4.46M |
|
$-4.46M |
|
$-4.46M |
|
$-4.46M |
|
$-4.46M |
|
$-4.46M |
|
$-0.50M |
|
|
EBITDA |
$-0.47M |
1.37M |
|
1.37M |
|
$-3.26 |
|
$-3.26 |
|
| Balance Sheet Financials | |
$7.58M |
|
$0.01M |
|
$0.21M |
|
$7.79M |
|
$1.84M |
|
-- |
|
$1.42M |
|
$3.25M |
|
$4.53M |
|
$4.49M |
|
$4.53M |
|
1.37M |
|
| Cash Flow Statement Financials | |
$-3.62M |
|
$0.75M |
|
$0.01M |
|
$4.24M |
|
$1.38M |
|
$-2.87M |
|
$-1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.37% |
|
-34.43% |
|
-34.43% |
|
-- |
|
-306.39% |
|
-306.39% |
|
$-3.62M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.55 |
|
1.15 |
|
78.19 |
|
-98.35% |
|
-99.20% |
|
-57.24% |
|
-98.35% |
|
$3.32 |
|
$-2.65 |
|
$-2.65 |
|